Dietary vitamin D3 suppresses pulmonary immunopathology associated with late-stage tuberculosis in C3HeB/FeJ mice

Journal of Immunology

Volumn 196, Issue 3, 2016, Pages 1293-1304

  Reeme, Allison E ^a   Robinson, Richard T ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; COLECALCIFEROL; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 23 P40; UNCLASSIFIED DRUG; VITAMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CD3+ T LYMPHOCYTE; CONTROLLED STUDY; EXPERIMENTAL TUBERCULOSIS; GENE EXPRESSION; HEMATOPOIETIC CELL; IMMUNOMODULATION; IMMUNOPATHOLOGY; IN VIVO STUDY; LUNG GRANULOMATOSIS; LUNG TUBERCULOSIS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TH1 CELL; VITAMIN SUPPLEMENTATION; ANIMAL; DIET; DISEASE MODEL; FLOW CYTOMETRY; IMAGE PROCESSING; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; INBRED MOUSE STRAIN; LUNG; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ANIMALS; CHOLECALCIFEROL; DIET; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LUNG; MICE; MICE, INBRED STRAINS; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TUBERCULOSIS, PULMONARY; VITAMINS;

EID: 84957651276     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500931     Document Type: Article

References (64)

1. Cooper, A. M. 2009. Cell-mediated immune responses in tuberculosis. Annu. Rev. Immunol. 27: 393-422.
2. World Health Organization 2015. Global Tuberculosis Report 2015. Available at: http://www.who.int/tb/publications/global-report/en/. Accessed: April 21, 2015
3. Dye, C., P. Glaziou, K. Floyd, and M. Raviglione. 2013. Prospects for tuberculosis elimination. Annu. Rev. Public Health 34: 271-286.
4. Urdahl, K. B. 2014. Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis. Semin. Immunol. 26: 578-587.
5. Miller, H. E., and R. T. Robinson. 2012. Early control of Mycobacterium tuberculosis infection requires il12rb1 expression by rag1-dependent lineages. Infect. Immun. 80: 3828-3841.
6. Reeme, A. E., H. E. Miller, and R. T. Robinson. 2013. IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis. Tuberculosis 93: 343-356.
7. Green, A. M., R. Difazio, and J. L. Flynn. 2013. IFN-g from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobac-terium tuberculosis infection. J. Immunol. 190: 270-277.
8. Achkar, J. M., and E. R. Jenny-Avital. 2011. Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response. J. Infect. Dis. 204(Suppl. 4): S1179-S1186.
9. Medzhitov, R., D. S. Schneider, and M. P. Soares. 2012. Disease tolerance as a defense strategy. Science 335: 936-941.
10. Hölscher, C., A. Hölscher, D. Rückerl, T. Yoshimoto, H. Yoshida, T. Mak, C. Saris, and S. Ehlers. 2005. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J. Immunol. 174: 3534-3544.
11. Barber, D. L., K. D. Mayer-Barber, C. G. Feng, A. H. Sharpe, and A. Sher. 2011. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J. Immunol. 186: 1598-1607.
12. Lázár-Molnár, E., B. Chen, K. A. Sweeney, E. J. Wang, W. Liu, J. Lin, S. A. Porcelli, S. C. Almo, S. G. Nathenson, and W. R. Jacobs, Jr. 2010. Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuber-culosis. Proc. Natl. Acad. Sci. USA 107: 13402-13407.
13. Kiran, D., B. K. Podell, M. Chambers, and R. J. Basaraba. 2015. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review. Semin. Immunopathol. In press.
14. Skerry, C., J. Harper, M. Klunk, W. R. Bishai, and S. K. Jain. 2012. Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas. PLoS One 7: e39680. doi:10.1371/journal.pone.0039680
15. Tsenova, L., B. Mangaliso, G. Muller, Y. Chen, V. H. Freedman, D. Stirling, and G. Kaplan. 2002. Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis. Antimicrob. Agents Chemother. 46: 1887-1895.
16. Ralph, A. P., R. M. Lucas, and M. Norval. 2013. Vitamin D and solar ultraviolet radiation in the risk and treatment of tuberculosis. Lancet Infect. Dis. 13: 77-88.
17. Bouillon, R., G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay. 2008. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29: 726-776.
18. Esteban, C., M. Geuskens, J. M. Ena, Z. Mishal, A. Macho, J. M. Torres, and J. Uriel. 1992. Receptor-mediated uptake and processing of vitamin D-binding protein in human B-lymphoid cells. J. Biol. Chem. 267: 10177-10183.
19. Green, M. 2011. Cod liver oil and tuberculosis. BMJ 343: d7505.
20. Greenstein, R. J., L. Su, and S. T. Brown. 2012. Vitamins A & D inhibit the growth of mycobacteria in radiometric culture. PLoS One 7: e29631. doi: 10.1371/journal.pone.0029631
21. Crowle, A. J., M. Salfinger, and M. H. May. 1989. 1, 25(OH)2-Vitamin D3 synergizes with pyrazinamide to kill tubercle bacilli in cultured human macro-phages. Am. Rev. Respir. Dis. 139: 549-552.
22. Liu, P. T., S. Stenger, H. Li, L. Wenzel, B. H. Tan, S. R. Krutzik, M. T. Ochoa, J. Schauber, K. Wu, C. Meinken, et al. 2006. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
23. Fabri, M., S. Stenger, D. M. Shin, J. M. Yuk, P. T. Liu, S. Realegeno, H. M. Lee, S. R. Krutzik, M. Schenk, P. A. Sieling, et al. 2011. Vitamin D is required for IFN-g-mediated antimicrobial activity of human macrophages. Sci. Transl. Med. 3: 104ra102.
24. Liu, P. T., S. Stenger, D. H. Tang, and R. L. Modlin. 2007. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J. Immunol. 179: 2060-2063.
25. Modlin, R. L., and B. R. Bloom. 2013. TB or not TB: that is no longer the question. Sci. Transl. Med. 5: 213sr6.
26. Castan-eda-Delgado, J., R. Hernández-Pando, C. J. Serrano, D. Aguilar-León, J. León-Contreras, C. Rivas-Santiago, R. Méndez, I. González-Curiel, A. Enciso-Moreno, and B. Rivas-Santiago. 2010. Kinetics and cellular sources of cath-elicidin during the course of experimental latent tuberculous infection and progressive pulmonary tuberculosis. Clin. Exp. Immunol. 161: 542-550.
27. 3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 377: 242-250.
28. Wejse, C., V. F. Gomes, P. Rabna, P. Gustafson, P. Aaby, I. M. Lisse, P. L. Andersen, H. Glerup, and M. Sodemann. 2009. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 179: 843-850.
29. Daley, P., V. Jagannathan, K. R. John, J. Sarojini, A. Latha, R. Vieth, S. Suzana, L. Jeyaseelan, D. J. Christopher, M. Smieja, and D. Mathai. 2015. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial. Lancet Infect. Dis. 15: 528-534.
30. Ralph, A. P., G. Waramori, G. J. Pontororing, E. Kenangalem, A. Wiguna, E. Tjitra, D. B. Sandjaja, D. B. Lolong, T. W. Yeo, M. D. Chatfield, et al. 2013. L-Arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. PLoS One 8: e70032. doi: 10.1371/journal.pone.007003
31. Irwin, S. M., V. Gruppo, E. Brooks, J. Gilliland, M. Scherman, M. J. Reichlen, R. Leistikow, I. Kramnik, E. L. Nuermberger, M. I. Voskuil, and A. J. Lenaerts. 2014. Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas. Antimicrob. Agents Che-mother. 58: 4026-4034.
32. Marzo, E., C. Vilaplana, G. Tapia, J. Diaz, V. Garcia, and P. J. Cardona. 2014. Damaging role of neutrophilic infiltration in a mouse model of progressive tuberculosis. Tuberculosis 94: 55-64.
33. Apt, A., and I. Kramnik. 2009. Man and mouse TB: contradictions and solutions. Tuberculosis 89: 195-198.
34. Driver, E. R., G. J. Ryan, D. R. Hoff, S. M. Irwin, R. J. Basaraba, I. Kramnik, and A. J. Lenaerts. 2012. Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 56: 3181-3195.
35. Harper, J., C. Skerry, S. L. Davis, R. Tasneen, M. Weir, I. Kramnik, W. R. Bishai, M. G. Pomper, E. L. Nuermberger, and S. K. Jain. 2012. Mouse model of ne-crotic tuberculosis granulomas develops hypoxic lesions. J. Infect. Dis. 205: 595-602.
36. Li, Y. C., A. E. Pirro, M. Amling, G. Delling, R. Baron, R. Bronson, and M. B. Demay. 1997. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA 94: 9831-9835.
37. Rowling, M. J., C. Gliniak, J. Welsh, and J. C. Fleet. 2007. High dietary vitamin D prevents hypocalcemia and osteomalacia in CYP27B1 knockout mice. J. Nutr. 137: 2608-2615.
38. Sergeev, I. N., and Q. Song. 2014. High vitamin D and calcium intakes reduce diet-induced obesity in mice by increasing adipose tissue apoptosis. Mol. Nutr. Food Res. 58: 1342-1348.
39. Meeker, S., A. Seamons, J. Paik, P. M. Treuting, T. Brabb, W. M. Grady, and L. Maggio-Price. 2014. Increased dietary vitamin D suppresses MAPK signaling, colitis, and colon cancer. Cancer Res. 74: 4398-4408.
40. Mathieu, C., E. Van Etten, C. Gysemans, B. Decallonne, S. Kato, J. Laureys, J. Depovere, D. Valckx, A. Verstuyf, and R. Bouillon. 2001. In vitro and in vivo analysis of the immune system of vitamin D receptor knockout mice. J. Bone Miner. Res. 16: 2057-2065.
41. Mayne, C. G., J. A. Spanier, L. M. Relland, C. B. Williams, and C. E. Hayes. 2011. 1, 25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. Eur. J. Immunol. 41: 822-832.
42. Johnson, L. E., and H. F. DeLuca. 2001. Vitamin D receptor null mutant mice fed high levels of calcium are fertile. J. Nutr. 131: 1787-1791.
43. Chackerian, A. A., J. M. Alt, T. V. Perera, C. C. Dascher, and S. M. Behar. 2002. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect. Immun. 70: 4501-4509.
44. + T cells in autoimmune disease. Front. Immunol. 6: 100.
45. + myeloid-derived suppressor cells in Mycobacterium tuberculosis infection. PLoS One 8: e80669. doi:10.1371/journal.pone.0080669
46. Casadevall, A., and L. A. Pirofski. 2003. The damage-response framework of microbial pathogenesis. Nat. Rev. Microbiol. 1: 17-24.
47. Hunter, R. L., C. Jagannath, and J. K. Actor. 2007. Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs. Tuberculosis 87: 267-278.
48. Orme, I. M., and R. J. Basaraba. 2014. The formation of the granuloma in tuberculosis infection. Semin. Immunol. 26: 601-609.
49. Ellman, P., and K. H. Anderson. 1948. Calciferol in tuberculous peritonitis with disseminated tuberculosis. BMJ 1: 394.
50. Nielsen, N. O., T. Skifte, M. Andersson, J. Wohlfahrt, B. Søborg, A. Koch, M. Melbye, and K. Ladefoged. 2010. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. Br. J. Nutr. 104: 1487-1491.
51. Gibney, K. B., L. MacGregor, K. Leder, J. Torresi, C. Marshall, P. R. Ebeling, and B. A. Biggs. 2008. Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa. Clin. Infect. Dis. 46: 443-446.
52. Flynn, J. L. 2006. Lessons from experimental Mycobacterium tuberculosis infections. Microbes Infect. 8: 1179-1188.
53. Hunter, R. L. 2011. Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis 91: 497-509.
54. Kramnik, I., W. F. Dietrich, P. Demant, and B. R. Bloom. 2000. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 97: 8560-8565.
55. Dietrich, J., S. Roy, I. Rosenkrands, T. Lindenstrøm, J. Filskov, E. M. Rasmussen, J. Cassidy, and P. Andersen. 2015. Differential influence of nutrient-starved Mycobacterium tuberculosis on adaptive immunity results in progressive tuberculosis disease and pathology. Infect. Immun. 83: 4731-4739.
56. Pan, H., B. S. Yan, M. Rojas, Y. V. Shebzukhov, H. Zhou, L. Kobzik, D. E. Higgins, M. J. Daly, B. R. Bloom, and I. Kramnik. 2005. Ipr1 gene me-diates innate immunity to tuberculosis. Nature 434: 767-772.
57. + regulatory T cell pool in mice that display excessive lung inflammation and increased susceptibility to Mycobacterium tuberculosis. Infect. Immun. 80: 1128-1139.
58. Coussens, A. K., R. J. Wilkinson, Y. Hanifa, V. Nikolayevskyy, P. T. Elkington, K. Islam, P. M. Timms, T. R. Venton, G. H. Bothamley, G. E. Packe, et al. 2012. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc. Natl. Acad. Sci. USA 109: 15449-15454.
59. Chen, C., Q. Liu, L. Zhu, H. Yang, and W. Lu. 2013. Vitamin D receptor gene polymorphisms on the risk of tuberculosis, a meta - Analysis of 29 case-control studies. PLoS One 8: e83843. doi:10.1371/journal.pone.0083843
60. Naranbhai, V., A. V. Hill, S. S. Abdool Karim, K. Naidoo, Q. Abdool Karim, G. M. Warimwe, H. McShane, and H. Fletcher. 2014. Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy. J. Infect. Dis. 209: 500-509.
61. Naranbhai, V., S. Kim, H. Fletcher, M. F. Cotton, A. Violari, C. Mitchell, S. Nachman, G. McSherry, H. McShane, A. V. Hill, and S. A. Madhi. 2014. The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life. BMC Med. 12: 120.
62. Naranbhai, V., D. Moodley, T. Chipato, L. Stranix-Chibanda, C. Nakabaiito, M. Kamateeka, P. Musoke, K. Manji, K. George, L. M. Emel, et al. 2014. The association between the ratio of monocytes: lymphocytes and risk of tuberculosis among HIV-infected postpartum women. J. Acquir. Immune Defic. Syndr. 67: 573-575.
63. Coussens, A. K., A. R. Martineau, and R. J. Wilkinson. 2014. Anti-inflammatory and antimicrobial actions of vitamin D in combating TB/HIV. Scientifica 2014: 903680.
64. Tameris, M. D., M. Hatherill, B. S. Landry, T. J. Scriba, M. A. Snowden, S. Lockhart, J. E. Shea, J. B. McClain, G. D. Hussey, W. A. Hanekom, et al. 2013. Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial. Lancet 381: 1021-1028.